Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Ltd Live Price Chart
Performance
| Previous Close | ₹ 191.22 |
| High | ₹ 181.66 |
| Volume | 7225 |
| 52W Range | ₹ 117.25 - ₹ 219.5 |
| Open | ₹ 181.66 |
| Low | ₹ 181.66 |
| Market Cap | ₹ 619.52 Cr |
Kilitch Drugs (India) Ltd Technicals
| 20 Day | ₹ 188.456 |
| 50 Day | ₹ 183.610 |
| 100 Day | ₹ 177.941 |
| 200 Day | ₹ 175.259 |
| 20 Day | ₹ 186.523 |
| 50 Day | ₹ 185.786 |
| 100 Day | ₹ 170.153 |
| 200 Day | ₹ 171.069 |
Kilitch Drugs (India) Ltd Fundamentals
| ROCE | 10.441 |
| P/E Ratio | 20.270 |
| P/B Ratio | 1.970 |
| Industry P/E | 1.970 |
| Debt to Equity | 50.605 |
| ROE | 9.729 |
| EPS | 9.270 |
| Dividend Yield | 0.000 |
| Book Value | 95.249 |
| Face Value | 10.000 |
Kilitch Drugs (India) Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 202.4228 | 195.3026 | 137.7875 | 122.3811 | 109.7188 |
| Total Expenses | 160.8691 | 154.6127 | 114.4344 | 102.9325 | 95.7906 |
| Profit After Tax | 32.3996 | 31.1568 | 17.5738 | 15.7173 | 10.5277 |
Kilitch Drugs (India) Ltd Shareholding Pattern
| Promoter Holdings | 63.774 % |
| FIIs | 0.117 % |
| DIIs | 0.001 % |
| MutualFund | 0.000 % |
| Retail | 29.640 % |
| Others - | 6.469 % |
About Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range of pharmaceutical formulations in the various dosage forms like Solid, Liquid and Parental across the globe. Its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms of creating safe pharmaceutical solutions. The Company went public in Feb.'94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules, liquid orals, ointments, creams and injectables. Even before the plant was commissioned, the company came out with a rights issue in Oct.'95 to expand the capacity. Commercial production at the plant at Thane commenced in 1996. The company has two divisions - O T C and ethical. A Pharmaceutical formulation plant at Sana'a Republic of Yemen was set up at a cost of Rs 15 crore by entering into an agreement with Al-Fath Trading Corporation. It also entered into an agreement with a Miami company for the export of their medicine to West Indies, south and central America. The company entered into a contract with one of the leading company in the Republic of Yemen which it had set up at a cost of Rs 2.5-cr tanning unit, which was implemented in the year 1995-96. The company had set up a bulk drug unit at Patalganga, Maharashtra for produc ...
FAQs on Kilitch Drugs (India) Ltd
1. Can I buy Kilitch Drugs (India) Ltd from PL Capital? ›
2. Does Kilitch Drugs (India) Ltd pay dividends? ›
3. What is the current share price of Kilitch Drugs (India) Ltd ? ›
4. What is the 52-week high and low of Kilitch Drugs (India) Ltd ? ›
Start SIP in Kilitch Drugs (India) Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
